Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparison
- DOI
- 10.1038/s41408-024-01044-4
- Published
- 2024-05-02
- Container
- Blood Cancer Journal
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41408-024-01044-4,
title = {Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparison},
author = {Mazyar Shadman and Alessandra Tedeschi and Leyla Mohseninejad and Keri Yang and Nicole Lamanna and Sheng Xu and Aileen Cohen and Swetha Challagulla and Mei Xue and Rhys Williams and Susan M. O’Brien and Jennifer R. Brown and Constantine Tam},
year = {2024},
journal = {Blood Cancer Journal},
doi = {10.1038/s41408-024-01044-4},
url = {https://doi.org/10.1038/s41408-024-01044-4}
}RIS
TY - JOUR TI - Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparison AU - Mazyar Shadman AU - Alessandra Tedeschi AU - Leyla Mohseninejad AU - Keri Yang AU - Nicole Lamanna AU - Sheng Xu AU - Aileen Cohen AU - Swetha Challagulla AU - Mei Xue AU - Rhys Williams AU - Susan M. O’Brien AU - Jennifer R. Brown AU - Constantine Tam PY - 2024 JO - Blood Cancer Journal DO - 10.1038/s41408-024-01044-4 UR - https://doi.org/10.1038/s41408-024-01044-4 ER -
APA
Shadman, M., Tedeschi, A., Mohseninejad, L., Yang, K., Lamanna, N., Xu, S., Cohen, A., Challagulla, S., Xue, M., Williams, R., O’Brien, S. M., Brown, J. R., & Tam, C. (2024). Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparison. Blood Cancer Journal. https://doi.org/10.1038/s41408-024-01044-4
Source records
- crossref · retrieved 2026-09-26T06:55:09.109Z